Niels Henrik Hollander

5PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 09, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.

Timothy Iveson, Mark P Saunders, Caroline Kelly

|Sep 19, 2024
Home self-testing of complete blood counts in patients with breast cancer during chemotherapy: A proof-of-concept cohort study in e-oncology.

Lennart Friis-Hansen, Pippi Jonassen Bjørck, Ditte Hartvig

|Jan 13, 2021
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.

Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino

|Dec 20, 2019
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Timothy Iveson, Kathleen A Boyd, Rachel S Kerr

|Nov 06, 2019
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.

Inna M Chen, Astrid Z Johansen, Christian Dehlendorff

Pageof 1

Frequent Collaborators

3 joint publications

Timothy J Iveson

3 joint publications

Andrea Harkin

2 joint publications

John McQueen

2 joint publications

Rene K Olesen